secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001698530-22-000103
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Exicure board shrinks from 5 to 4; two directors resign; new director appointed; audit committee non-compliant
--------------------------------------------------------------------------------

- James Sulat and Bali Muralidhar resigned from the Board effective December 30, 2022.
- Board size decreased from five to four directors.
- Jiyoung Hwang appointed to Board as lead purchaser designee from CBI USA.
- Audit Committee now has only two independent directors, breaching Nasdaq Listing Rule 5605(c)(2)(A).
- Company expects to regain compliance within one-year cure period or next annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853022000103/0001698530-22-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853022000103/xcur-20221230.htm
  HTML page:      https://secwatch.observer/filing/0001698530-22-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer